VirTus Respiratory Research

We are a unique CRO pursuing excellence in accelerating respiratory research. We provide preclinical studies (in vivo and in vitro) as well as human challenge studies for respiratory diseases (Rhinovirus and Respiratory syncytial virus). We develop new respiratory treatments, vaccines and anti-virals in an extremely time and cost-efficient manner. Virtus is a unique CRO providing pre-clinical and human challenge clinical study services, with a focus on Asthma and COPD. Virtus provides world-class expertise in human challenge studies and pre-clinical studies in respiratory research. Virtus provides a bespoke academic approach to the design, supervision and analysis of respiratory studies. Our team is composed of experts within their field, with a diverse range of experience, scientific and management skills. The Virtus founders have worked together since 2001 and our top-tier team provides unparalleled expertise in virus-related research.